Skip to content

A mindful yoga intervention for young women with major depressive disorder: Design and baseline sample characteristics of a randomized controlled trial

Nina K. Vollbehr, Rogier Hoenders, Agna A. Bartels‐Velthuis, Maaike H. Nauta, Stynke Castelein, Maya J. Schroevers, A Dennis Stant, Peter J. de Jong, Brian D. Ostafin

International Journal of Methods in Psychiatric Research February 17, 2020 DOI: 10.1002/mpr.1820 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Randomized controlled trial Peer reviewed
Population Young females aged 18-34 years with major depressive disorder
Interventions Mindful yoga intervention treatment as usual
Duration 9-week intervention; assessments at preintervention, postintervention, 6-month, and 12-month follow-up
Measures Hamilton Depression Rating Scale, Depression-Anxiety-Stress Scales
Topics Depression
Citations 17
Key findings The trial is designed to test whether a 9-week manualized mindful yoga intervention added to treatment as usual improves depression outcomes and cost-effectiveness compared with treatment as usual alone in young women with major depressive disorder, and to examine potential mechanisms such as rumination, negative self-evaluation, intolerance of uncertainty, interoceptive awareness, and dispositional mindfulness. No outcome results are reported in this abstract.

Abstract

Objectives: Despite the gains made by current first-line interventions for major depressive disorder (MDD), modest rates of treatment response and high relapse indicate the need to augment existing interventions. Following theory and initial research indicating the promise of mindful yoga interventions (MYIs), this study examines mindful yoga as a treatment of MDD. METHODS/DESIGN: This randomized controlled trial uses a sample of young females (18-34 years) to examine the efficacy and cost-effectiveness of a 9-week manualized MYI added to treatment as usual (TAU) versus TAU alone. Primary outcome measures consist of clinician-administered (Hamilton Depression Rating Scale) and self-report (Depression-Anxiety-Stress Scales) measures of depression. Underlying mechanisms will be examined, including rumination, negative self-evaluation, intolerance of uncertainty, interoceptive awareness, and dispositional mindfulness. Assessments were conducted at preintervention and will be conducted at postintervention, 6-, and 12-month follow up.

Results: = 9.36).

Conclusion: This trial will provide important information regarding the benefits of adding yoga-based interventions to TAU for young women with MDD and the mechanisms through which such benefits may occur.

Comparable studies

Other randomized controlled trials on depression, most cited first.

Study Year Design Participants
A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major Depression Subjects with DSM-IV major depression (treatment resistant) 2006 Randomized, placebo-controlled, double-blind crossover study n = 18
Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Recovered recurrently depressed patients 2000 Randomized controlled trial n = 145
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Cancer patients with life-threatening diagnoses and symptoms of depression and/or anxiety 2016 Randomized controlled trial n = 51
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Patients with cancer-related anxiety and depression 2016 Double-blind, placebo-controlled, crossover trial n = 29
Mindfulness-Based Cognitive Therapy for Depression: Replication and Exploration of Differential Relapse Prevention Effects. Recovered recurrently depressed patients 2004 Randomized controlled trial n = 73

Citations in the library

Explore topics